about
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosisA model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients.Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclGDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides.Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in endothelial progenitor cells.Multiple pathways of cell invasion are regulated by multiple families of serine proteases.The plasminogen activation system in inflammation.Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma.The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation.Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities.Endothelial sphingosine kinase/SPNS2 axis is critical for vessel-like formation by human mesoangioblasts.Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells.ENDOTHELIAL PROGENITOR CELLS AS SHUTTLE OF ANTICANCER AGENTS.EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts.Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases.Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in miceEndothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice.Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters.Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis.Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells.Urokinase and its receptor in follicular and inflammatory cysts of the jaws.TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesisErratum: Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapyThe Mr 17500 region of the A chain of urokinase is required for interaction with a specific receptor in A431 cellsAdhesion-dependent heparin production by plateletsInvolvement of chondroitin sulphate in preventing adhesive cellular interactionsCell surface glycosaminoglycans in normal and leukemic leukocytesInvolvement of glycosaminoglycans in detachment of early myeloid precursors from bone-marrow stromal cellsGlycosaminoglycan changes involved in polymorphonuclear leukocyte activation in vitroProduction of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptorNon-enzymatic activities of proteases: from scepticism to realityGrowth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic systemPlasminogen activators and inhibitor type-1 in alveolar osteitisMatrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesisModulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12
P50
Q28279380-17BDC948-7FE4-4CF8-B178-B5748E3BB9C6Q30478833-4594ACA7-4B10-4623-963F-EC6E34005C6AQ33264935-849B422F-792B-4233-A8CA-09B1673AA939Q34505275-4DC11F20-73FE-4948-B9FA-2E2EE36616F5Q34661515-30BDD174-DAE0-4290-8B47-C91911E20BCBQ34687536-54087ED4-D049-4BCE-ABE5-82C6DCD41880Q37175368-B27FE1E1-2C20-47A4-8876-266EAC787F82Q37457696-3581900E-143F-4619-A6B2-033532920802Q37895300-BF6237A6-7A8E-46F9-A1E8-BF9FE14D7301Q38304820-7E5986CE-3D3B-46B8-8BC5-E243A5199DC6Q38878001-8C7E08AA-C7C3-428A-B682-CA1FEDEA0C0FQ38908272-29AB4020-E635-462A-BFDC-027C70B02D76Q38922167-05746E22-1D8E-4F58-97E1-5249F08F3B1CQ39295109-DBED0838-7E06-4362-9350-3ABEFF03B379Q39706283-60252B95-9C51-4741-9753-6E98ADACFB91Q39793015-5A8A6193-DE62-4B07-BF4A-CE4C8D5B49C0Q40026208-07844B60-92B1-45A4-BFD4-59747762375AQ40571595-8E743245-461B-4095-85CE-7F096A1C7ED9Q41120487-3F70775B-C5B7-41C7-A93F-C41D5C34E98EQ41577789-305A218E-C98B-4976-ABFC-5DCE984415CCQ43097972-12677470-4235-42B1-9818-ED9BED33F886Q45304157-07FC5855-045E-4B58-8262-2ABDF413B207Q45555792-1625CDE2-436C-4760-AE17-5909B0D3AF17Q53311342-DAE1FF45-C050-4DDD-9761-DFADB6453982Q56893657-2C66A995-0434-4879-80E0-27F101D16006Q64071032-4cbde6dd-4329-f52e-8dd2-c46c7a9e55a3Q70126397-70172DC6-22CB-4D53-8725-8E837EAE296FQ70294545-5E464BCE-E0C4-443E-AE77-A94F841BE59EQ70440165-1778C042-8ACD-484B-BC4F-0826A782D919Q71208596-213C58E1-93B3-4A2E-AF57-D85758B0763CQ71561794-9BF84698-6E9F-4DDD-8E33-7B516FA89AB0Q71606414-5C3860AA-6BBD-4D5D-943F-B6A298C8DCA1Q72106859-CF594ECA-9584-433E-A020-07B378025654Q77865541-881502FC-2250-4945-A938-3177B89D3200Q77865572-E6D89D5D-2EB6-44FB-B9B1-567E7830B177Q79446755-8E3E88CB-1B4F-41E6-80CD-1E3E2EEFE146Q80845141-120B80C1-8B3C-4FE3-8F05-D40AAE6A0BB9Q84309344-328AB5B0-4B08-43FE-BBC0-9B0230F6851E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gabriella Fibbi
@ast
Gabriella Fibbi
@en
Gabriella Fibbi
@es
Gabriella Fibbi
@nl
type
label
Gabriella Fibbi
@ast
Gabriella Fibbi
@en
Gabriella Fibbi
@es
Gabriella Fibbi
@nl
prefLabel
Gabriella Fibbi
@ast
Gabriella Fibbi
@en
Gabriella Fibbi
@es
Gabriella Fibbi
@nl
P106
P1153
7003514047
P21
P31
P496
0000-0002-0629-851X